Unique combination of hyaluronic acid and amino acids in the management of patients with a wide range of moderate‐to‐severe chronic wounds: Evidence from international clinical practice

Abstract

AbstractThe availability of new products and strategies to manage wounds has taken a quantum leap in recent years. Healthcare professionals now have an extensive range of products to choose from, but while positive this also raises dilemmas in real‐world clinical practice to decide on the most appropriate treatment for a given patient. Clinical trials confirm the effectiveness of the unique combination of hyaluronic acid and amino acids (Vulnamin®) in a range of wounds, but are these results replicated in real‐world clinical practice? International experts presented their clinical experience with the use of the combination in difficult‐to‐treat wounds. The objective was to reach a consensus on how and when to use the unique combination products to provide a cost‐effective, convenient option, in all healthcare settings that improves QoL for patients and their carers.